Strain of Bifidobacterium animalis ssp. animalis
AssigneeCompagnie Gervais Danone
InventorsSophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
Life of this patent
Estimating the term…
Abstract
The invention relates to a novel strain of Bifidobacterium animals ssp. animalis, which is able, inter alia, to improve the function of the enteric nervous system, and to compositions said novel strain.
Claims11
A composition comprising the Bifidobacterium animalis subspecies animalis strain deposited on 6 Mar. 2012 under number I-4602 with the CNCM (Collection Nationale de Cultures de Microorganismes) (strain Bifidobacterium animalis subspecies animalis CNCM I-4602), wherein the composition is a fermented dairy food product.
A method of preventing and/or reducing gastro-intestinal discomfort or gastro-intestinal disorders, comprising administering the strain Bifidobacterium animalis subspecies animalis CNCM I-4602 to a subject in need thereof.
A method of increasing vaso-active intestinal peptide (VIP) levels of the enteric nervous system in a subject, comprising administering the strain Bifidobacterium animalis subspecies animalis CNCM I-4602 to a subject in need thereof.
A method of improving gastro-intestinal motility, improving intestinal peristalsis and/or decreasing intestinal permeability, comprising administering the strain Bifidobacterium animalis subspecies animalis CNCM I-4602 to a subject in need thereof.
Dependencies are inferred from the claim text.